Weighing risks and benefits of liraglutidethe FDA's review of a new antidiabetic therapy
Follow-up began on the index date and continued until the earliest of the following: occurrence of a study outcome, death, loss to follow-up, or one year
New patients will start on 1.5mg, with doses increasing to 4mg, 9mg and 25mg, with at least one month at each level
No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
Key takeaways Semaglutide fatigue is real and happens because the medication lowers blood sugar and reduces food intake, leaving you with less available energy